Stakeholder Input
Authors
- Pages
- 191
- Published in
- Canada
CADTH Reimbursement Review - Odevixibat (Bylvay) - Sponsor: Medison Pharma Canada Inc.
10 May 2024
Accessing this content requires a membership
If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.
Add to list
Citation
Health, C., 2024. CADTH Reimbursement Review - Odevixibat (Bylvay) - Sponsor: Medison Pharma Canada Inc., Canadian Agency for Drugs and Technologies in Health.
Canada.
Retrieved from https://coilink.org/20.500.12592/gmsbjww on 23 Oct 2024. COI: 20.500.12592/gmsbjww.
Full-page Screenshot
